According to the last WHO situation report (10 March 2020), the novel Coronavirus disease
2019 (COVID-19) has been confirmed in 113 702 patients, most of them in China (71.1%) …

Patients with rheumatic diseases (RD) have a higher risk of morbidity and mortality from
vaccine-preventable infections attributed to disease activity, comorbidities …

Background: Reports dealing with clinical outcomes of classical Hodgkin's lymphoma in low-
to middle-income countries are scarce and response to therapy is poorly documented. This …

Background and Aims Information comparing treatment outcome for diffuse large B cell
(DLBCL) and follicular (FL) non-Hodgkin lymphoma (NHL) patients treated with schemes …

There is scarce information regarding the concentration of cytokines in cerebrospinal fluid
(CSF) of children with acute lymphoblastic leukemia (ALL) and their clinical association with …

We thank Zhang et al for the interest showed in our letter 1 and appreciate their comments
about the care of rheumatic patients during the COVID-19 pandemic. 2 We agree that the …

Recently, the journal published the 2019 update of the European League Against
Rheumatism (EULAR) recommendations for the management of systemic lupus …

We thank Xie et al 1 for the interest in our letter 2 and found some relevant points to discuss
the role of antimalarial drugs during the COVID-19 pandemic. The information has increased …

Background Influenza virus infection is frequently characterized by a complex clinical
behavior and outcomes can be fatal. There are many published scoring methods aimed for …

Objective The classification and/or diagnosis of Primary Sjögren's Syndrome (PSS) requires
a multidimensional approach. Although age and the duration of sicca symptoms can affect …